Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors

Journal of Biotechnology

Volumn 44, Issue 1-3, 1996, Pages 193-196

  Levine, Myron M ^a   Galen, James ^a   Barry, Eileen ^a   Noriega, Fernando ^a   Chatfield, Steven ^b   Sztein, Marcelo ^a   Dougan, Gordon ^b   Tacket, Carol ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Attenuated Salmonella typhi; Live vector; Oral vaccine; Salmonella typhi

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BACTERIA; DISEASES; IMMUNOLOGY;

ATTENUATED SALMONELLA TYPHI; CELL MEDIATED IMMUNE RESPONSES; IMMUNOGENICITY; LIVE VECTORS; ORAL VACCINES; SALMONELLA TYPHI; TYPHOID FEVER;

VACCINES;

LIVE VACCINE;

ANTIGEN EXPRESSION; ATTENUATION; CLINICAL TRIAL; CONFERENCE PAPER; EXPRESSION VECTOR; HUMAN; IMMUNOGENICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALMONELLA TYPHI; TYPHOID FEVER; VACCINATION;

EID: 0030022501     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-1656(95)00094-1     Document Type: Conference Paper

References (19)

1. Chatfield, S., Strahan, K., Pickard, D., Charles, I.G., Hormaeche, C.E. and Dougan, G. (1992a) Evaluation of Salmonella typhimurium strains harboring defined mutations in htrA and aroA in the murine salmonellosis model. Microb. Pathogen 12, 145-151.
2. Chatfield, S., Charles, I., Makoff, A., Dougan, G., Pickard, D., Slater, D. and Fairweather, N. (1992b) Use of the nirB promoter to direct the stable expression of heterologous anti-gens in Salmonella oral vaccine strains: Development of a single-dose oral tetanus vaccine. Bio/Technology 2, 888-890.
3. Curtiss, R., III and Kelly, S. (1987) Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun. 55, 3035-3043.
4. Galen, J.E., Gómez-Duarte, O., Chatfield, S., Eidels, L., Rappuoli, R. and Levine, M.M. (1995) Expression of a stable tetanus toxin fragment C-diphtheria protein fusion in the attenuated Salmonella typhi CVD 908 vaccine strain. Presented at Keystone Symposium on Mucosal Immunity: New Strategies for Protection against Viral and Bacterial Pathogens. J Cell. Biochem. (Suppl.) 19A, 297.
5. Gómez-Duarte, O.G., Galen, J., Chatfield, S.N., Rappuoli, R., Eidels, L. and Levine, M.M. (1995) Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain. Vaccine, in press.
6. Gonzalez, C., Hone, D., Noriega, F., Tacket, C.O., Davis, J.R., Losonsky, G., Nataro, J.P., Hoffman, S., Malik, A., Nardin, E., Sztein, M.B., Heppner, D.G., Fouts, T.R., Isibasi, A. and Levine, M.M. (1994) Salmonella typhi strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction, safety and immunogenicity. J. Infect. Dis. 169, 927-931.
7. Hone, D.M., Attridge, S., Forrest, B., Morona, R., Daniels, D., LaBrooy, J.T., Bartholomeusz, R.C.A., Shearman, D.J.C., Hackett, J. (1988) A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans. Infect. Immun. 56, 1326-1333.
8. Hone, D.M., Harris, A.M., Chatfield, S., Dougan, G. and Levine, M.M. (1991) Construction of genetically-defined double aro mutants of Salmonella typhi. Vaccine 9, 810-816.
9. Hone, D.M., Tacket, CO., Harris, A.M., Kay, B., Losonsky, G. and Levine, M.M. (1992) Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vaccine. J. Clin. Invest. 90, 412-420.
10. Kantele, A. (1990) Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine. Vaccine 8, 321-326.
11. Khan, C.M.A., Villarreal-Ramos, B., Pierce, R.J., Demarco de Hormaeche, R., McNeill, H., Ali, T., Chatfield, S., Capron, A., Dougan, G. and Hormaeche, C.E. (1994) Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Proc. Natl. Acad. Sci. USA 91, 11261-11265.
12. Levine, M.M., Ferreccio, C., Black, R.E., Chilean Typhoid Committee and Germanier, R. (1987) Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet i, 1049-1052.
13. Levine, M.M., Ferreccio, C., Black, R.E., Tacket, C.O., Germanier, R. and Chilean Typhoid Committee (1989) Progress in vaccines to prevent typhoid fever. Rev. Infect. Dis. 11 (Suppl. 3), S552-S567.
14. Levine, M.M., Ferreccio, C., Cryz, S. and Ortiz, E. (1990) Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in a randomized controlled field trial. Lancet 336, 891-894.
15. Miller, S.I., Loomis, W.P., Alpuche-Aranda, C., Behlau, I. and Hohmann, E. (1993) The PhoP virulence regulon and live oral Salmonella vaccines. Vaccine 11, 122-125.
16. Pickard, D., Li, J., Roberts, M., Maskell, D., Hone, D., Levine, M.M., Dougan, G. and Chatfield, C. (1994) Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression. Infect. Immun. 62, 3984-3993.
17. Sztein, M.B., Wasserman, S.S., Tacket, C.O., Edelman, R., Hone, D., Lindberg, A.A. and Levine, M.M. (1994) Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J. Infect. Dis. 170, 1508-1517.
18. Tacket, C.O., Hone, D.M., Curtiss, R., III, Kelly, S.M., Losonsky, G., Guers, L., Harris, A.M., Edelman, R. and Levine, M.M. (1992a) Comparison of the safety and immunogenicity of aroC,aroD and cya.crp Salmonella typhi strains in adult volunteers. Infect. Immun. 60, 536-541.
19. Tacket, C.O., Hone, D.M., Losonsky, G., Guers, L., Edelman, R. and Levine, M.M. (1992b) Clinical acceptability and immuno-genicity of CVD 908 Salmonella typhi vaccine strain. Vaccine 10, 443-446.